November 30, 2020 10:17 AM EST
Coronavirus

Covid-19 roundup: No­vavax de­lays US, Mex­i­co vac­cine tri­al (again); In­dia in­ves­ti­gates re­port­ed side ef­fects in As­traZeneca study

Amber Tong

Nicole DeFeudis

Editor

No­vavax is de­lay­ing the start of its US/Mex­i­co Phase III tri­al a sec­ond time, even as it com­pletes en­roll­ment for two oth­er stud­ies of its …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

To lead NIH, Trump taps Stan­ford aca­d­e­m­ic and pan­dem­ic re­sponse crit­ic Jay Bhat­tacharya

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

Ad­vanz Phar­ma faces re­vo­ca­tion of Eu­ro­pean au­tho­riza­tion for liv­er dis­ease drug Ocali­va

Bris­tol My­ers sues the fed­er­al gov­ern­ment over 340B, fol­low­ing oth­er drug­mak­ers

A service from the Financial Times